Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy

Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy

to compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy.

To compare the analgesia and side effect of nalbuphine and morphine for elective Laparoscopic myomectomy, by using patient controlled analgesia postoperatively, a randomized, double blind clinical trial. Patients undergoing elective Laparoscopic myomectomy are randomly divided into two groups: nalbuphine and morphine groups. All patients are under general anesthesia with routine methods. The nalbuphine group receive postoperative patient controlled analgesia using nalbuphine 30mg/120ml, while the morphine group receive postoperative patient controlled analgesia using morphine 60mg/120ml. Perioperative parameters are to be collected to compare the two groups.

Inclusion Criteria:

• elective Laparoscopic myomectomy patients 24hr post-operative patient controlled analgesia analgesia no mild or severe liver or renal disfunction

Exclusion Criteria:

• can't understand patient controlled analgesia device refuse trial